Comparison of 18F-FET and 18F-FDG PET in brain tumors
- 31 October 2009
- journal article
- clinical trial
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 36 (7), 779-787
- https://doi.org/10.1016/j.nucmedbio.2009.05.005
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain AbscessesJournal of Nuclear Medicine, 2007
- Clinical Applications of PET in Brain TumorsJournal of Nuclear Medicine, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemiaNuclear Medicine and Biology, 2006
- O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2006
- Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent GliomasNeurosurgery, 2005
- Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-l-tyrosine and magnetic resonance spectroscopyJournal of Neurosurgery, 2005
- O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain, 2005
- Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent gliomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004